BPMUF
Price:
$60.275
Market Cap:
$610.17M
Basilea Pharmaceutica AG is a biopharmaceutical company already generating revenue from its products, which are designed to fulfill medical needs in the challenging areas of cancer (oncology) and infectious diseases (anti-infectives). The company's product portfolio includes Cresemba, an azole antifungal drug administered intravenously or orally. This medication is approved for treating invasive aspergillosis and mucormycosis in both the United States and the European Union. Additionally, Cresemba is undergoing Phase III clinical trials in Japan for addressing invasive fungal infections. Another key product is Zevtera, an antibiotic prescribed for both community-acquired and hospital-acquire...[Read more]
Industry
Biotechnology
IPO Date
2015-06-09
Stock Exchange
OTC
Ticker
BPMUF
According to Basilea Pharmaceutica AG’s latest financial reports and current stock price. The company's current ROE is 27.95%. This represents a change of -49.28% compared to the average of 55.11% of the last 4 quarters.
The mean historical ROE of Basilea Pharmaceutica AG over the last ten years is 25.46%. The current 27.95% ROE has changed 9.81% with respect to the historical average. Over the past ten years (40 quarters), BPMUF's ROE was at its highest in in the June 2016 quarter at 311.24%. The ROE was at its lowest in in the December 2015 quarter at -211.95%.
Average
25.46%
Median
27.77%
Minimum
-104.48%
Maximum
146.53%
Discovering the peaks and valleys of Basilea Pharmaceutica AG ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 78.17%
Maximum Annual ROE = 146.53%
Minimum Annual Increase = -603.09%
Minimum Annual ROE = -104.48%
| Year | ROE | Change |
|---|---|---|
| 2025 | 31.42% | -67.20% |
| 2024 | 95.80% | -191.69% |
| 2023 | -104.48% | 78.17% |
| 2022 | -58.64% | -603.09% |
| 2021 | 11.66% | -19.21% |
| 2020 | 14.43% | -40.19% |
| 2019 | 24.12% | -48.70% |
| 2018 | 47.01% | 0.63% |
| 2017 | 46.72% | -68.12% |
| 2016 | 146.53% | -135.34% |
The current ROE of Basilea Pharmaceutica AG (BPMUF) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
7.58%
5-year avg
-4.85%
10-year avg
25.46%
Basilea Pharmaceutica AG’s ROE is less than Viva Biotech Holdings (5.57%), greater than Nxera Pharma Co., Ltd. (-15.58%), less than GenSight Biologics S.A. (42.20%), less than Avisa Diagnostics Inc. (408.59%), less than YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (5.87%), greater than Valneva SE (-106.22%), greater than PureTech Health plc (-31.98%), less than Beijing Tong Ren Tang Chinese Medicine Company Limited (9.74%), less than Swedencare AB (publ) (0.72%), less than MedinCell S.A. (84.89%),
| Company | ROE | Market cap |
|---|---|---|
| 5.57% | $284.79M | |
| -15.58% | $567.36M | |
| 42.20% | $30.99M | |
| 408.59% | $97.18K | |
| 5.87% | $643.13M | |
| -106.22% | $489.29M | |
| -31.98% | $413.81M | |
| 9.74% | $542.78M | |
| 0.72% | $500.30M | |
| 84.89% | $1.23B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Basilea Pharmaceutica AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Basilea Pharmaceutica AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Basilea Pharmaceutica AG's ROE?
How is the ROE calculated for Basilea Pharmaceutica AG (BPMUF)?
What is the highest ROE for Basilea Pharmaceutica AG (BPMUF)?
What is the 3-year average ROE for Basilea Pharmaceutica AG (BPMUF)?
What is the 5-year average ROE for Basilea Pharmaceutica AG (BPMUF)?
How does the current ROE for Basilea Pharmaceutica AG (BPMUF) compare to its historical average?